Lack of significant changes on magnetic resonance scans before and after 2 weeks of daily left prefrontal repetitive transcranial magnetic stimulation for depression

The Journal of ECT
Z NahasM S George

Abstract

Repetitive transcranial magnetic stimulation (rTMS) is a new technology for exploring brain function. With this method, a small electromagnet is placed on the scalp; by activating and deactivating it, nerve cells in the underlying superficial cortex are depolarized. Several studies have found that prefrontal rTMS has potential efficacy in treating depression, and this technology, in addition to being a research tool, may soon play a role in psychiatric practice. Thus, establishing the safety of this technology is important and has been studied insufficiently. The authors performed T1-weighted three-dimensional volumetric magnetic resonance (MR) imaging on 22 depressed adults (15 active, 7 control) before and after they participated in a 2-week double-blinded, placebo-controlled trial of daily left prefrontal rTMS for the treatment of depression (a total of 16,000 stimuli). Seventeen patients also had paired T2-weighted scans. In a blinded manner, MR scans were qualitatively and quantitatively assessed for structural changes. No qualitative structural differences were observed before and after treatment. In addition, volumetric analysis of the prefrontal lobe showed no changes in the 2 weeks of the study. In conclusion, 10 days ...Continue Reading

References

Apr 1, 1992·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Y MatsumiyaJ W Kling
Mar 1, 1991·Electroencephalography and Clinical Neurophysiology·S A CounterL Lofqvist
Jan 1, 1991·Annals of Biomedical Engineering·J M SaypolM Hallett
Jan 1, 1990·Neuroscience·M RavnborgM Blinkenberg
Apr 1, 1993·Electroencephalography and Clinical Neurophysiology·A Pascual-LeoneL G Cohen
Oct 1, 1993·Electroencephalography and Clinical Neurophysiology·S A Counter
Jan 1, 1993·Archives of General Psychiatry·C E CoffeyC E Spritzer
Jan 1, 1996·The Journal of Neuropsychiatry and Clinical Neurosciences·M S GeorgeR M Post
Nov 13, 1998·The American Journal of Psychiatry·N GrisaruR H Belmaker
Apr 10, 1999·Archives of General Psychiatry·M S GeorgeH A Sackeim
Dec 14, 1999·Psychiatry and Clinical Neurosciences·S Pridmore, R Belmaker

❮ Previous
Next ❯

Citations

Dec 14, 2002·Brain and Cognition·Sulekha Anand, John Hotson
Jul 15, 2003·Neurosurgery Clinics of North America·Mark S GeorgeBenjamin D Greenberg
Apr 12, 2002·Acta Psychiatrica Scandinavica·P B FitzgeraldZ J Daskalakis
Aug 26, 2011·Audiology & Neuro-otology·Hsiung-Kwang ChungMing-Hsui Tsai
Dec 14, 2011·Neurophysiologie clinique = Clinical neurophysiology·J-P LefaucheurL Garcia-Larrea
Jun 5, 2003·The British Journal of Psychiatry : the Journal of Mental Science·José Luis R MartinJaime Kulisevsky
Aug 16, 2005·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Wim Simons, Michel Dierick
Feb 4, 2010·The Veterinary Journal·Iris Van Soens, Luc M Van Ham
Oct 17, 2009·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Simone RossiUNKNOWN Safety of TMS Consensus Group
Sep 21, 2007·The International Journal of Neuropsychopharmacology·Colleen K LooPhilip B Mitchell
May 23, 2007·Clinical EEG and Neuroscience·Anne RauFrank Padberg
Jun 12, 2003·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·XingBao LiMark S George
Nov 19, 2002·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Sarah H LisanbyMichael J Crupain
Dec 13, 2002·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·David B MacDonald
Jun 22, 2002·The Cochrane Database of Systematic Reviews·J L MartinA Gironell
Oct 25, 2017·Human Brain Mapping·Timm B PoepplMartin Schecklmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.